Author: AlShoaibi, Naeem A.; Maghrabi, Khadijah; Alanazi, Haitham; Harbi, Mousa Al; Alghamdi, Saleh
Title: Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19 Cord-id: n21jryi2 Document date: 2020_9_20
ID: n21jryi2
Snippet: Evidence of cardiovascular complications associated with the COVID-19 global pandemic continues to evolve. These include direct and indirect myocardial injury with subsequent acute myocardial ischemia, and cardiac arrhythmia. Some results from a limited number of trials of antiviral medications, along with chloroquine/hydroxychloroquine and azithromycin, have been beneficial. However, these pharmacotherapies may cause drug-induced QT prolongation leading to ventricular arrhythmias and sudden car
Document: Evidence of cardiovascular complications associated with the COVID-19 global pandemic continues to evolve. These include direct and indirect myocardial injury with subsequent acute myocardial ischemia, and cardiac arrhythmia. Some results from a limited number of trials of antiviral medications, along with chloroquine/hydroxychloroquine and azithromycin, have been beneficial. However, these pharmacotherapies may cause drug-induced QT prolongation leading to ventricular arrhythmias and sudden cardiac death. Mitigation of the potential risk in these susceptible patients may prove exceptionally challenging. The Saudi Heart Rhythm Society established a task force to perform a review of this subject based on has recently published reports, and studies and recommendations from major medical organizations. The objective of this review is to identify high-risk patients, and to set clear guidelines for management of patients receiving these pharmacotherapies.
Search related documents:
Co phrase search for related documents- abnormal repolarization and long qt syndrome: 1
- acute coronary syndrome and lopinavir ritonavir: 1, 2
- acute illness and lopinavir ritonavir: 1, 2, 3, 4, 5, 6
- acute illness and lopinavir ritonavir azithromycin: 1
- acute injury and liver enzyme: 1, 2, 3, 4, 5
- acute injury and long qt syndrome: 1
- acute injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute injury and lopinavir ritonavir azithromycin: 1, 2, 3
- acute myocardial ischemia and long qt syndrome: 1
- acute respiratory distress and liver enzyme: 1, 2, 3, 4, 5, 6
- acute respiratory distress and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory distress and lopinavir ritonavir azithromycin: 1, 2, 3, 4, 5, 6, 7, 8, 9
- liver enzyme and lopinavir ritonavir: 1, 2, 3, 4
- liver enzyme and lopinavir ritonavir azithromycin: 1
- long qt interval and lopinavir ritonavir: 1
- long qt interval and lopinavir ritonavir azithromycin: 1
- long qt syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6
- long qt syndrome and lopinavir ritonavir azithromycin: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date